James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 199,195 shares at $8.48 ($1.7M) on 2018-06-14, disclosed to the SEC on 2018-06-20.
Open-market sale of $1.7M GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.99 | 31,860 | $255K | 15.0% |
| 2 | $7.99 | 31,860 | $255K | 15.0% |
| 3 | $8.48 | 44,525 | $378K | 22.3% |
| 4 | $8.47 | 15,475 | $131K | 7.7% |
| 5 | $8.47 | 15,475 | $131K | 7.7% |
| 6 | $9.06 | 60,000 |
| $544K |
| 32.1% |
| Total | $8.50 avg | 199,195 | $1.7M | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |